Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001805035-20-000001
Filing Date
2020-03-12
Accepted
2020-03-12 13:08:19
Documents
1
Effectiveness Date
2020-03-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9818
  Complete submission text file 0001805035-20-000001.txt   10833
Mailing Address 500 ELLIS ST MOUNTAIN VIEW CA 94043
Business Address 500 ELLIS ST MOUNTAIN VIEW CA 94043 650-428-1800
Amunix Pharmaceuticals, Inc. (Filer) CIK: 0001805035 (see all company filings)

EIN.: 271108708 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-362661 | Film No.: 20707935